Abstract
Cervical cancer is associated with human papilloma virus infection. However, this infection is insufficient to induce transformation and progression. Loss of heterozygosity analyses suggest the presence of a tumor suppressor gene (TSG) on chromosome 6p21.3–p25. Here we report the cloning NOL7, its mapping to chromosome band 6p23, and localization of the protein to the nucleolus. Fluorescence in situ hybridization analysis demonstrated an allelic loss of an NOL7 in cultured tumor cells and human tumor samples. Transfection of NOL7 into cervical carcinoma cells inhibited their growth in mouse xenografts, confirming its in vivo tumor suppressor activity. The induction of tumor dormancy correlated with an angiogenic switch caused by a decreased production of vascular endothelial growth factor and an increase in the production of the angiogenesis inhibitor thrombospondin-1. These data suggest that NOL7 may function as a TSG in part by modulating the expression of the angiogenic phenotype.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Bouck N, Stellmach V, Hsu H . (1995). Adv Cancer Res 69: 135–174.
Cannistra SA, Niloff JM . (1996). N Engl J Med 334: 1030–1038.
Chen T, Pecoraro G, Defendi V . (1993). Cancer Res 53: 1167–1171.
Chen Z, Issa B, Brothman LJ, Hendricksen M, Button D, Brothman AR . (2000). Cancer Genet Cytogenet 121: 22–25.
Claudio PP, Stiegler P, Howard CM, Bellan C, Minimo C, Tosi GM et al. (2001). Cancer Res 61: 462–468.
Coignet LJ, Lima CS, Min T, Streubel B, Swansbury J, Telford N et al. (1999). Genes Chrom Cancer 25: 222–229.
Dameron KM, Volpert OV, Tainsky MA, Bouck N . (1994). Science 2651: 582–584.
Dejong V, Degeorges A, Filleur S, Ait-Si-Ali S, Mettouchi A, Bornstein P et al. (1999). Oncogene 18: 3143–3151.
Gnarra JR, Zhou S, Merrill MJ, Wagner JR, Krumm A, Papavassiliou E et al. (1996). Proc Natl Acad Sci USA 93: 10589–10594.
Hanahan D, Folkman J . (1996). Cell 86: 353–364.
Huettner PC, Gerhard DS, Li L, Gersell DJ, Dunnigan K, Kamarasova T et al. (1998). Hum Pathol 29: 364–370.
Jinawath N, Furukawa Y, Nakamura Y . (2004). Cancer Sci 95: 430–435.
Kersemaekers AM, Kenter GG, Hermans J, Fleuren GJ, van de Vijver MJ . (1998). Int J Cancer 79: 411–417.
Kraemer M, Tournaire R, Dejong V, Montreau N, Briane D, Derbin C et al. (1999). Cell Growth Differ 10: 193–200.
Lazo PA . (1999). Br J Cancer 80: 2008–2018.
Lingen MW . (2002). Wound Healing: Methods and Protocols. Totowa, NJ: Humana Press, Inc, pp. 337–347.
Lingen MW, DiPietro LA, Solt DB, Bouck NP, Polverini PJ . (1997). Carcinogenesis 18: 329–338.
Lingen MW, Polverini PJ, Bouck NP . (1998). Cancer Res 58: 5551–5558.
Marconcini L, Marchio S, Morbidelli L, Cartocci E, Albini A, Ziche M et al. (1999). Proc Natl Acad Sci USA 96: 9671–9676.
Mitra AB, Murty VV, Li RG, Pratap M, Luthra UK, Chaganti RS . (1994). Cancer Res 54: 4481–4487.
Montgomery K, Tedford KL, McDougall JK . (1995). Genes Chromosomes Cancer 14: 97–105.
Mukhopadhyay D, Tsiokas L, Sukhatme VP . (1995). Cancer Res 55: 6161–6165.
Mullokandov MR, Kholodilov NG, Atkin NB, Burk RD, Johnson AB, Klinger HP . (1996). Cancer Res 56: 197–205.
Nagai H, Kinoshita T, Suzuki H, Hatano S, Murate T, Saito H . (1999). Genes Chromosomes Cancer 25: 277–283.
Nakase K, Wakita Y, Minamikawa K, Yamaguchi T, Shiku H . (2000). Leuk Res 24: 79–81.
Olson MO, Dundr M, Szebeni A . (2000). Trends Cell Biol 10: 189–196.
Rader JS, Li Y, Huettner PC, Xu Z, Gerhard DS . (2000). Genes Chromosomes Cancer 27: 373–379.
Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T et al. (1995). Cancer Res 55: 4575–4580.
Sheibani N, Frazier WA . (1996). Cancer Lett 107: 45–52.
Slack JL, Bornstein P . (1994). Cell Growth Differ 5: 1373–1380.
Srivastava S, Tong YA, Devadas K, Zou ZQ, Chen Y, Pirollo KF et al. (1992). Carcinogenesis 13: 1273–1275.
Sugimoto M, Kuo M-L, Roussel MF, Sherr CJ . (2003). Mol Cell 11: 415–424.
Takeshita A, Naito K, Shinjo K, Sahara N, Matsui H, Ohnishi K et al. (2004). Cancer Genet Cytogenet 152: 56–60.
Tikhonenko AT, Black DJ, Linial ML . (1996). J Biol Chem 271: 30741–30747.
Uejima H, Mitsuya K, Kugoh H, Horikawa I, Oshimura M . (1995). Genes Chromosomes Cancer 14: 120–127.
Visintin R, Amon A . (2000). Curr Opin Cell Biol 12: 372–377.
Volpert OV, Dameron KM, Bouck N . (1997). Oncogene 14: 1495–1502.
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. (1999). J Pathol 189: 12.
Watnick RS, Cheng YN, Rangarajan A, Ince TA, Weinberg RA . (2003). Cancer Cell 3: 219–231.
Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D . (1999). Nat Cell Biol 1: 20–29.
Wen S, Stolarov J, Myers MP, Su JD, Wigler MH, Tonks NK et al. (2001). Proc Natl Acad Sci USA 98: 4622–4627.
Wolf JK, Ramirez PT . (2001). Cancer Invest 19: 621–629.
Yaginuma Y, Westphal H . (1991). Cancer Res 51: 6506–6509.
Zabrenetzky V, Harris CC, Steeg PS, Roberts DD . (1994). Int J Cancer 59: 191–195.
Zhang YW, Su Y, Volpert OV, Vande Woude GF . (2003). Proc Natl Acad Sci USA 100: 12718–12723.
Acknowledgements
This work was supported in part by the NIH grants: DE12322 and DE00470 (MWL).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)
Supplementary information
supplementary Table
26 Commonly Upregulated Genes in SiHa Clone 3 and Clone 4 When Compared to SiHa Parental (XLS 63 kb)
Rights and permissions
About this article
Cite this article
Hasina, R., Pontier, A., Fekete, M. et al. NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype. Oncogene 25, 588–598 (2006). https://doi.org/10.1038/sj.onc.1209070
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209070
Keywords
This article is cited by
-
NOL7 facilitates melanoma progression and metastasis
Signal Transduction and Targeted Therapy (2021)
-
Genomic approaches to identify hybrids and estimate admixture times in European wildcat populations
Scientific Reports (2019)
-
RaRF confers RA resistance by sequestering RAR to the nucleolus and regulating MCL1 in leukemia cells
Oncogene (2018)
-
The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression
Oncogene (2013)
-
Identification of a 7-gene signature that predicts relapse and survival for early stage patients with cervical carcinoma
Medical Oncology (2012)